Drawing for READYE_LEASE

USPTO serial 79285906

READYE_LEASE

Reviewed by CopyMark Law Group

Reg. 6248173Status 700Renewal
Filing date
Status date
Registration date
Jan 19, 2021
Examiner
RIBAUDO,MICHELLE RACHEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with READYE_LEASE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter S. Sloane

Peter S. Sloane Leason Ellis LLPOne North Lexington Ave., Suite 1200White Plains, NY 10601United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biological and biochemical products, namely, antibody-dye conjugates for industrial, scientific and diagnostic purposes other than for medical use; reagents for use in separation processes for biological materials, for non-medical purposes; reagents for cell separation for non-medical purposes; cell labeling reagents for non-medical purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of materials, especially of chemical and biological material, for non-medical purposes; reagents with magnetic beads for cell separation, for non-medical purposes; antibody reagents used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use other than for medical or veterinary purposes; buffer solutions and reagents for use with laboratory instruments, especially separation instruments, analysis instruments, reactors and imaging instruments, for non-medical purposes; reagents for processing of biological material, especially tissue, bone marrow, cells, blood and its components other than for medical or veterinary purposes; diagnostic reagents and preparations, in particular for separation, isolation, enrichment, depletion, detection, screening, imaging and analysis of biological material, for scientific purposes; culture media, cell culture media, freezing media, contrast agents, contrast agents for in-vivo imaging, all for scientific purposes; reagents for use in biotechnology, in biological treatment processes and in the biotechnology industry, for non-medical purposesACTIVE—
005Pharmaceutical, medical and veterinary products as well as products for the pharmaceutical, medical and veterinary science, namely, antibody-dye conjugates for medical or veterinary purposes; reagents for medical or veterinary purposes, cell culturing media for medical or veterinary purposes, materials and ingredients for the preparation of cell culturing media for medical or veterinary purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of material, especially of biological materials, reagents with magnetic beads, and antibody reagents, all for medical or veterinary purposes; buffer solutions and reagents for use with medical instruments, especially separation instruments, analysis instruments, reactor and imaging instruments all for medical or veterinary purposes; reagents for the processing of biological material, especially tissue, bone marrow, cells, blood and its components, all for medical or veterinary purposes; culture media, cell culture media, diagnostic reagents and preparations for medical and veterinary purposes; freezing media, contrast agents, contrast agents for in-vivo imaging, all for medical and veterinary purposes; pharmaceutical products, especially pharmaceutical products for the cellular therapyACTIVE—
042Scientific and technological services in the nature of analyzing biological and biochemical material and research and design services relating hereto; industrial analysis and research services, namely, cell detection and isolation; design and development of computer hardware and software for the analysis of biological and biochemical material, all of the aforementioned services for and in connection with the analysis of biological and biochemical material, especially of cellular material for biological and medical research and therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 19, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 15, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 15, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 15, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 16, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 22, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 21, 2021FIMPFINAL DISPOSITION PROCESSED—
Apr 19, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 19, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 3, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 3, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 14, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 29, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 29, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Sep 29, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 29, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 29, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 24, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 24, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 23, 2020ALIEASSIGNED TO LIE—
Aug 25, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 24, 2020RFNTREFUSAL PROCESSED BY IB—
Jul 14, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 14, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 14, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 14, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 14, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 14, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 8, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 8, 2020RFRRREFUSAL PROCESSED BY MPU—
Jun 8, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 7, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
May 29, 2020DOCKASSIGNED TO EXAMINER—
May 27, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 21, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance